Researcher Eva Rohde and her team awarded with distinction

8. November 2021

Philip Levine Research Award for Salzburg team

Eva Rohde and her team at Paracelsus Medical University are being awarded the Philip Levine Prize by the German Society for Transfusion Medicine and Immunohematology for their outstanding scientific work.

Great hopes are being placed worldwide in research with extracellular vesicles, which is considered one of the most important cell therapies of the future. The Good Manufacturing Practice Laboratory, abbreviated as GMP Laboratory Salzburg, is among the few academic-pharmaceutical institutions worldwide that can produce vesicles for administration to humans.

International institutions such as the biotech company Paracrine Therapeutics from Singapore collaborate with this centerpiece of the Center for Cross-Sectional and Tissue Regeneration. Salzburg plays an outstanding role in terms of equipment, expertise, and quality.

Vesicles – more than just “garbage”

Extracellular vesicles, long dismissed as the “garbage system” of cells, have an important communication function in the body: they transmit targeted information between cells, organs, and even between different organisms. Vesicles have potential as gatekeeper systems. Their role is particularly promising in regenerative medicine.

“It’s like two soap bubbles merging with each other,” explains Rohde. “The information thus reaches the target cell.” Research groups from Essen, Hannover, and Salzburg, in addition to the GMP laboratory, play an important role. New therapeutics based on vesicles are being developed in a cleanroom environment.

A significant advantage of these tiny powerhouses is their volume, which is at a ratio of 1:3,000,000 compared to the cell. They have the ability to suppress inflammatory processes and reduce scar formation. This tremendous potential could be an important key, for example, in the healing of hearing implants in the inner ear.

You might also be interested in

11. November 2025

Eleven Million Euros for Five New Research Centers

Salzburg is investing in research: around eleven million euros from EU and state funds will go toward establishing five new research and transfer centers. They cover key future-oriented topics: artificial intelligence, climate protection, health, tourism, and data security.

6. March 2025

salz21: Necessary Steps for the Future

On March 5, 2025, salz21 | Home of Innovation once again provided a platform for future topics, innovations, and interdisciplinary exchange. More than 1,000 visitors took the opportunity to learn about current developments and discuss perspectives for tomorrow. Three topics were particularly dominant: climate protection, artificial intelligence, and a strong Europe.

20. September 2024

15 Million Euros for Salzburg’s Life Sciences Future

The federal government and the Province of Salzburg are jointly investing in research, education and medical innovation. The new Life Sciences Masterplan strengthens cooperation between University of Salzburg, Paracelsus Medical University and Salzburg University Hospital, focusing on cancer research, neuroscience and regenerative medicine.

6. September 2024

Franz-Benjamin Mocnik researches the communication of places.

In Salzburg, there is an exciting digitization research project: Franz-Benjamin Mocnik is studying the communication of places for the Faculty of DAS.

Our Newsletter